Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Intratympanic Dexamethasone for ISSNHL
NCT00335920Phase 3Completed
- Sponsor
- University Hospital Tübingen
- Start
- Oct 2003
- Primary completion
- Jul 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in idiopathic sudden sensorineural hearing loss (ISSNHL) comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Pure tone audiometric threshold. Started Oct 2003; status: completed.
02
Drugs
dexamethasone
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on NCT00335920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335920.